C.J. Twelves

1.5k total citations
55 papers, 987 citations indexed

About

C.J. Twelves is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, C.J. Twelves has authored 55 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in C.J. Twelves's work include Cancer Treatment and Pharmacology (29 papers), Colorectal Cancer Treatments and Studies (16 papers) and Breast Cancer Treatment Studies (12 papers). C.J. Twelves is often cited by papers focused on Cancer Treatment and Pharmacology (29 papers), Colorectal Cancer Treatments and Studies (16 papers) and Breast Cancer Treatment Studies (12 papers). C.J. Twelves collaborates with scholars based in United Kingdom, United States and Spain. C.J. Twelves's co-authors include N Dobbs, R.D. Rubens, G. Pentheroudakis, R L Souhami, RE Coleman, A. Lawrence Gould, Nicola Dobbs, Jim Cassidy, C. M. Ash and M A Richards and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

C.J. Twelves

53 papers receiving 945 citations

Peers

C.J. Twelves

ONCOL

PRM

SURGE

Jacques Camerlo France

T. Griffin United States

Anna Ceribelli Italy

C. Oberhoff Germany

Philippe Montcuquet France

F J Cummings United States

Artur Katz Brazil

Hans Wildiers Belgium

William Hyman United States

Gül Başaran Türkiye

Jacques Camerlo France

C.J. Twelves

448 ×0.6

ONCOL

162 ×0.6

PRM

190 ×0.9

172 ×1.9

61 ×0.7

SURGE

Citations per year, relative to C.J. Twelves C.J. Twelves (= 1×) peers Jacques Camerlo

Countries citing papers authored by C.J. Twelves

Since Specialization

Citations

This map shows the geographic impact of C.J. Twelves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. Twelves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. Twelves more than expected).

Fields of papers citing papers by C.J. Twelves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. Twelves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. Twelves. The network helps show where C.J. Twelves may publish in the future.

Co-authorship network of co-authors of C.J. Twelves

This figure shows the co-authorship network connecting the top 25 collaborators of C.J. Twelves. A scholar is included among the top collaborators of C.J. Twelves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J. Twelves. C.J. Twelves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chu, Eric Chun‐Pu, Daniel G. Haller, Thomas H. Cartwright, et al.. (2011). Epidemiology and natural history of central venous access device (CVAD) use and infusion pump performance among patients (pts) treated for metastatic colorectal cancer (mCRC): Analysis from the NO16966 trial.. Journal of Clinical Oncology. 29(15_suppl). e14010–e14010. 1 indexed citations

Twelves, C.J., J McKendrick, Oscar Bertetto, et al.. (2004). Pharmacoeconomic analysis of Capecitabine in the adjuvant setting. Results from the X-ACT trial comparing capecitabine with 5-FU/LV in patients with Dukes' C colon cancer. Annals of Oncology. 15. 73–73. 7 indexed citations

Twelves, C.J., et al.. (2002). Follow-up in women with breast cancer: the patients' perspective. The Breast. 11(3). 257–261. 15 indexed citations

Gatzemeier, U., C.J. Twelves, Alan Anthoney, et al.. (2001). A phase I dose-escalation study of zd0473 combined with paclitaxel in refractory solid malignancies. European Journal of Cancer. 37. S74–S75. 5 indexed citations

Piccart, M., P.F. Bruning, RE Coleman, et al.. (2000). AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282). Ghent University Academic Bibliography (Ghent University). 13 indexed citations

Macleod, Una, Sue Ross, C. Gillis, et al.. (2000). Socio-economic deprivation and stage of disease at presentation in women with breast cancer. Annals of Oncology. 11(1). 105–108. 51 indexed citations

Dewar, J, et al.. (1999). Breast Cancer in Scotland: Changes in Treatment and Work-Load. Clinical Oncology. 11(1). 52–54. 2 indexed citations

Dobbs, Nicola & C.J. Twelves. (1998). What is the effect of adjusting epirubicin doses for body surface area?. British Journal of Cancer. 78(5). 662–666. 26 indexed citations

Twelves, C.J., et al.. (1998). Entry into clinical trials in breast cancer: the importance of specialist teams. European Journal of Cancer. 34(7). 1004–1007. 28 indexed citations

10.

Macleod, Una, Sue Ross, C.J. Twelves, C. Gillis, & G. Watt. (1998). Breast cancer care: Does the NHS discriminate against women living in deprived areas?. European Journal of Cancer. 34. S74–S74. 1 indexed citations

11.

Dobbs, N & C.J. Twelves. (1998). Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?. British Journal of Cancer. 77(7). 1145–1148. 3 indexed citations

12.

Twelves, C.J., David A. Porter, M. Lowry, et al.. (1994). Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. British Journal of Cancer. 69(6). 1151–1156. 25 indexed citations

13.

Twelves, C.J., N Dobbs, Alison Curnow, et al.. (1994). A phase II, multicentre, UK study of vinorelbine in advanced breast cancer. British Journal of Cancer. 70(5). 990–993. 64 indexed citations

14.

Twelves, C.J., et al.. (1994). Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life. British Journal of Cancer. 69(4). 726–731. 18 indexed citations

15.

Twelves, C.J., N Dobbs, L. A. SUMMERS, et al.. (1992). Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests. British Journal of Cancer. 66(4). 765–769. 42 indexed citations

16.

Chaudhuri, R., C.J. Twelves, T.C.S. Cox, & John B. Bingham. (1992). MRI in diabetes insipidus due to metastatic breast carcinoma. Clinical Radiology. 46(3). 184–188. 21 indexed citations

17.

Twelves, C.J. & R L Souhami. (1991). Should cerebral metastases be treated by chemotherapy alone?. Annals of Oncology. 2(1). 15–17. 6 indexed citations

18.

Twelves, C.J., C. M. Ash, D.W. Miles, D. G. T. Thomas, & R L Souhami. (1991). Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma. Cancer Chemotherapy and Pharmacology. 27(6). 481–483. 23 indexed citations

19.

Twelves, C.J., R L Souhami, PG Harper, et al.. (1990). The response of cerebral metastases in small cell lung cancer to systemic chemotherapy. British Journal of Cancer. 61(1). 147–150. 67 indexed citations

20.

Twelves, C.J., et al.. (1989). Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry. British Journal of Cancer. 60(6). 938–941. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact